Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.3 and deleted Revision: v3.4.2 in the page’s version history. This is a minor update that does not modify the study content or results.SummaryDifference0.1%

- Check22 days agoChange DetectedA new site in Ciudad de Buenos Aires, Argentina (C1120AAT) was added on 2026-02-27, and the Buenos Aires, Argentina site was removed on 2025-10-28.SummaryDifference0.3%

- Check44 days agoChange DetectedRevision: v3.4.2 added; the page removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedNotice added about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status. Website revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check58 days agoChange DetectedShow glossary option added; several metadata labels updated or added (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0) while corresponding older labels and No FEAR Act data references (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) were removed or changed. These changes are limited to UI/metadata and do not affect core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.